Schroder Investment Management Group
SRPT icon

Schroder Investment Management Group’s Sarepta Therapeutics SRPT Stock Holding History

Schroder Investment Management Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-103,005
Closed -$2.11M – 1243
2026
Q1 		$2.11M Sell
103,005
-132,016
-56% -$2.56M ﹤0.01% 921
2025
Q4 		$5.05M Buy
+235,021
New +$4.95M ﹤0.01% 745
2025
Q3 		– Sell
-51,704
Closed -$884K – 1258
2025
Q2 		$884K Sell
51,704
-8,647
-14% -$369K ﹤0.01% 1006
2025
Q1 		$4.25M Buy
60,351
+54,828
+993% +$5.77M ﹤0.01% 789
2024
Q4 		$669K Buy
5,523
+2,320
+72% +$284K ﹤0.01% 1066
2024
Q3 		$399K Sell
3,203
-34,058
-91% -$4.71M ﹤0.01% 1131
2024
Q2 		$5.89M Buy
37,261
+20,075
+117% +$2.58M 0.01% 746
2024
Q1 		$2.22M Sell
17,186
-9,514
-36% -$1.17M ﹤0.01% 911
2023
Q4 		$2.57M Buy
+26,700
New +$2.56M ﹤0.01% 871
2021
Q2 		– Sell
-1,807
Closed -$135K – 1605
2021
Q1 		$135K Hold
1,807
– – ﹤0.01% 1358
2020
Q4 		$308K Buy
1,807
+1,204
+200% +$178K ﹤0.01% 1256
2020
Q3 		$81K Hold
603
– – ﹤0.01% 1247
2020
Q2 		$97K Buy
603
+229
+61% +$31.2K ﹤0.01% 1156
2020
Q1 		$38K Buy
+374
New +$42.8K ﹤0.01% 1237
2019
Q3 		– Sell
-2,402
Closed -$364K – 1315
2019
Q2 		$364K Buy
2,402
+84
+4% +$10.2K ﹤0.01% 1106
2019
Q1 		$276K Buy
+2,318
New +$298K ﹤0.01% 1047

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Schroder Investment Management Group's SRPT Position: Q2 2026 in Review

Schroder Investment Management Group sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 103,005 shares — an estimated $2.11M sold.

Schroder Investment Management Group first reported a position in SRPT in Q1 2019 and held it in 16 quarters. The position peaked at $5.89M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Schroder Investment Management Group reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 103,005 Sarepta Therapeutics shares in Q2 2026, an estimated $2.11M.
  • Schroder Investment Management Group first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 16 quarters.
  • Schroder Investment Management Group's Sarepta Therapeutics position peaked at $5.89M in Q2 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.